Profile data is unavailable for this security.
About the company
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.
- Revenue in USD (TTM)143.27m
- Net income in USD-66.43m
- Incorporated1998
- Employees409.00
- LocationBioLife Solutions IncSUITE 310, 3303 MONTE VILLA PARKWAYBOTHELL 98021United StatesUSA
- Phone+1 (425) 401-1400
- Fax+1 (425) 402-1433
- Websitehttps://www.biolifesolutions.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SI-Bone Inc | 138.89m | -43.34m | 585.99m | 344.00 | -- | 3.43 | -- | 4.22 | -1.13 | -1.13 | 3.62 | 4.16 | 0.716 | 1.57 | 6.52 | 403,738.40 | -22.34 | -27.88 | -25.24 | -30.94 | 78.78 | 85.03 | -31.20 | -51.09 | 8.15 | -- | 0.1756 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Embecta Corp | 1.12bn | 55.30m | 598.82m | 2.20k | 10.84 | -- | 6.66 | 0.5335 | 0.9598 | 0.9598 | 19.47 | -13.78 | 0.9296 | 2.57 | 19.35 | 510,181.80 | 4.58 | -- | 6.44 | -- | 66.55 | -- | 4.93 | -- | 1.75 | 1.67 | 1.94 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Fulgent Genetics Inc | 289.21m | -167.83m | 598.91m | 1.18k | -- | 0.5228 | -- | 2.07 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Jin Medical International Ltd | 19.98m | 3.25m | 613.66m | 269.00 | 175.63 | 25.80 | 171.49 | 30.72 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
| Treace Medical Concepts Inc | 187.12m | -49.53m | 637.94m | 516.00 | -- | 4.61 | -- | 3.41 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Varex Imaging Corp | 877.80m | 44.60m | 686.14m | 2.30k | 25.18 | 1.21 | 8.69 | 0.7817 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Silk Road Medical Inc | 177.13m | -55.74m | 691.43m | 474.00 | -- | 4.57 | -- | 3.90 | -1.44 | -1.44 | 4.56 | 3.86 | 0.6622 | 2.04 | 8.52 | 373,700.40 | -20.84 | -29.02 | -23.22 | -32.98 | 71.75 | 72.91 | -31.47 | -46.84 | 6.97 | -- | 0.3335 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Atrion Corp | 169.33m | 19.41m | 702.17m | 712.00 | 36.20 | 2.89 | 20.35 | 4.15 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Orthopediatrics Corp | 148.73m | -20.97m | 712.16m | 247.00 | -- | 1.86 | -- | 4.79 | -0.9251 | -0.9251 | 6.56 | 16.13 | 0.3433 | 0.4073 | 5.01 | 602,153.90 | -4.84 | -5.40 | -5.28 | -5.93 | 74.80 | 75.09 | -14.10 | -15.92 | 2.90 | -- | 0.026 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Cytek Biosciences Inc | 193.01m | -12.15m | 736.54m | 676.00 | -- | 1.87 | -- | 3.82 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Paragon 28 Inc | 216.39m | -47.84m | 743.67m | 430.00 | -- | 4.18 | -- | 3.44 | -0.5819 | -0.5819 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | 503,230.20 | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| BioLife Solutions Inc | 143.27m | -66.43m | 763.76m | 409.00 | -- | 2.26 | -- | 5.33 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Avanos Medical Inc | 673.30m | -9.90m | 824.74m | 3.77k | -- | 0.6667 | 22.78 | 1.22 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Artivion Inc | 354.00m | -30.57m | 845.46m | 1.50k | -- | 2.96 | -- | 2.39 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| MiMedx Group Inc | 321.48m | 55.80m | 917.76m | 895.00 | 24.20 | 6.40 | 14.31 | 2.85 | 0.2581 | 0.2192 | 2.19 | 0.976 | 1.57 | 3.19 | 6.63 | 359,192.20 | 32.86 | -4.14 | 42.03 | -5.90 | 83.01 | 83.61 | 20.98 | -2.70 | 3.11 | 7.11 | 0.256 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Perspective Therapeutics Inc | 8.17m | -25.10m | 939.51m | 88.00 | -- | 4.55 | -- | 114.98 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
Data as of Apr 25 2024. Currency figures normalised to BioLife Solutions Inc's reporting currency: US Dollar USD
61.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Casdin Capital LLCas of 31 Dec 2023 | 8.71m | 19.22% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 5.12m | 11.30% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 2.48m | 5.47% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2023 | 2.34m | 5.18% |
| Millennium Management LLCas of 31 Dec 2023 | 2.31m | 5.11% |
| William Blair Investment Management LLCas of 31 Dec 2023 | 1.71m | 3.78% |
| Fred Alger Management LLCas of 31 Dec 2023 | 1.63m | 3.59% |
| Granahan Investment Management, LLCas of 31 Dec 2023 | 1.29m | 2.85% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.25m | 2.76% |
| Palisade Capital Management LPas of 31 Dec 2023 | 1.21m | 2.68% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
